We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patient... Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome. Show more
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma PR Newswire CRANFORD, N.J., April 11...
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference PR Newswire CRANFORD, N.J., April 4, 2024 CRANFORD, N.J., April 4, 2024 /PRNewswire/ -- Citius...
Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIRβ’ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma PR...
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program PR Newswire CRANFORD, N.J., March 7, 2024 Net operating losses converted into non-dilutive...
Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration PR Newswire CRANFORD, N.J., Feb. 26, 2024 CRANFORD, N.J., Feb. 26...
Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences PR Newswire CRANFORD, N.J., Feb. 23, 2024 CRANFORD, N.J., Feb. 23, 2024 /PRNewswire/ -- Citius...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2725 | -27.806122449 | 0.98 | 1.04 | 0.7 | 2183211 | 0.77955986 | CS |
4 | -0.1025 | -12.6543209877 | 0.81 | 1.07 | 0.7 | 1294227 | 0.85530872 | CS |
12 | 0.0775 | 12.3015873016 | 0.63 | 1.07 | 0.6 | 845090 | 0.79417521 | CS |
26 | -0.0524 | -6.89564416371 | 0.7599 | 1.07 | 0.6 | 691638 | 0.77669172 | CS |
52 | -0.8525 | -54.6474358974 | 1.56 | 1.58 | 0.6 | 1050922 | 1.0040196 | CS |
156 | -1.0847 | -60.5233790872 | 1.7922 | 4.56 | 0.6 | 2002495 | 1.96713962 | CS |
260 | -0.3225 | -31.3106796117 | 1.03 | 4.56 | 0.4 | 2249455 | 1.82241234 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions